DALLAS, May 10, 2019 (GLOBE NEWSWIRE) -- -- via
OTC PR WIRE -- Puration, Inc. (PURA)
(“PURAâ€) and Nouveau, Inc. (Nouveau Life Pharmaceuticals dba
Nouveau) (NOUV) (“NOUVâ€) today confirmed
plans to issue a dividend of NOUV stock to PURA shareholders in
conjunction with the spinoff of PURA’s cannabis cultivation
business to NOUV. Next week, the two companies plan for NOUV
to launch a new company website. The website has been
strategically designed to facilitate next steps in the dividend
distribution of NOUV stock to PURA shareholders.
“As the CEO of PURA and the interim CEO of NOUV, I can tell you I
am pleased with the operational progress of both companies,†said
Brian Shibley. “PURA has recently expanded its production
operations of EVERx CBD Sports Water to include a second plant and
NOUV is moving forward with its first US hemp crop. Next week
PURA will introduce EVERx in South Africa at the Arnold Sports
Festival and NOUV’s making great strides in carving out its own
niche in the legal recreational marijuana market in
Canada.â€
To learn more about the two companies visit:
www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Contact:
Puration, Inc.
Brian Shibley,
[email protected]
(800) 861-1350